269 related articles for article (PubMed ID: 38334637)
1. Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer.
Underwood PW; Ruff SM; Pawlik TM
Cells; 2024 Jan; 13(3):. PubMed ID: 38334637
[TBL] [Abstract][Full Text] [Related]
2. Targeted Therapy for Colorectal Cancer.
Sakata S; Larson DW
Surg Oncol Clin N Am; 2022 Apr; 31(2):255-264. PubMed ID: 35351276
[TBL] [Abstract][Full Text] [Related]
3. Receipt of Targeted Therapy and Survival Outcomes in Patients With Metastatic Colorectal Cancer.
Koroukian SM; Booker BD; Vu L; Schumacher FR; Rose J; Cooper GS; Selfridge JE; Markt SC
JAMA Netw Open; 2023 Jan; 6(1):e2250030. PubMed ID: 36656585
[TBL] [Abstract][Full Text] [Related]
4. A review of targeted therapy and immune checkpoint inhibitors for metastatic colorectal cancer.
Ruff SM; Brown ZJ; Pawlik TM
Surg Oncol; 2023 Dec; 51():101993. PubMed ID: 37742544
[TBL] [Abstract][Full Text] [Related]
5. Role of Anti-Epidermal Growth Factor Receptor Therapy Compared with Anti-Vascular Endothelial Growth Factor Therapy for Metastatic Colorectal Cancer: an Update Meta-Analysis of Randomized Clinical Trials.
Wang JX; Wu HL; Zhu M; Zhou R
Pathol Oncol Res; 2020 Jan; 26(1):159-166. PubMed ID: 29383654
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy for metastatic colorectal cancer.
Price TJ; Tang M; Gibbs P; Haller DG; Peeters M; Arnold D; Segelov E; Roy A; Tebbutt N; Pavlakis N; Karapetis C; Burge M; Shapiro J
Expert Rev Anticancer Ther; 2018 Oct; 18(10):991-1006. PubMed ID: 30019590
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatment for metastatic colorectal cancer.
Leowattana W; Leowattana P; Leowattana T
World J Gastroenterol; 2023 Mar; 29(10):1569-1588. PubMed ID: 36970592
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcome comparisons of first-line targeted therapy in patients with KRAS wild-type metastatic colorectal cancer: A nationwide database study.
Liang YH; Chen KH; Shao YY
Cancer Med; 2023 Jul; 12(14):15176-15186. PubMed ID: 37325970
[TBL] [Abstract][Full Text] [Related]
9. A review on emerging targeted therapies for the management of metastatic colorectal cancers.
Deshmukh R; Prajapati M; Harwansh RK
Med Oncol; 2023 Apr; 40(6):159. PubMed ID: 37097307
[TBL] [Abstract][Full Text] [Related]
10. Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study.
Fang X; Zhong C; Weng S; Hu H; Wang J; Xiao Q; Wang J; Sun L; Xu D; Liao X; Dong C; Zhang S; Li J; Ding K; Yuan Y
BMC Cancer; 2023 Jul; 23(1):676. PubMed ID: 37464378
[TBL] [Abstract][Full Text] [Related]
11. Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer.
Kano Y; Suenaga M; Uetake H
Curr Oncol; 2023 Jul; 30(7):6546-6558. PubMed ID: 37504340
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Strategies in Diseases of the Digestive Tract - 2015 and Beyond Targeted Therapies in Colon Cancer Today and Tomorrow.
Pohl M; Schmiegel W
Dig Dis; 2016; 34(5):574-9. PubMed ID: 27332557
[TBL] [Abstract][Full Text] [Related]
13. Anti-EGFR and anti-VEGF agents: important targeted therapies of colorectal liver metastases.
Feng QY; Wei Y; Chen JW; Chang WJ; Ye LC; Zhu DX; Xu JM
World J Gastroenterol; 2014 Apr; 20(15):4263-75. PubMed ID: 24764664
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond.
Al Bitar S; El-Sabban M; Doughan S; Abou-Kheir W
World J Gastroenterol; 2023 Mar; 29(9):1395-1426. PubMed ID: 36998426
[TBL] [Abstract][Full Text] [Related]
15. [Targeted therapies for metastatic colorectal cancer].
Kito Y; Yamazaki K
Nihon Rinsho; 2015 Aug; 73(8):1384-90. PubMed ID: 26281694
[TBL] [Abstract][Full Text] [Related]
16. Precision Medicine in Metastatic Colorectal Cancer: Relevant Carcinogenic Pathways and Targets-PART 1: Biologic Therapies Targeting the Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor.
Weinberg BA; Hartley ML; Salem ME
Oncology (Williston Park); 2017 Jul; 31(7):539-48. PubMed ID: 28712098
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract][Full Text] [Related]
18. The current status and prospect of immunotherapy in colorectal cancer.
Shu Y; Zheng S
Clin Transl Oncol; 2024 Jan; 26(1):39-51. PubMed ID: 37301804
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review.
Biller LH; Schrag D
JAMA; 2021 Feb; 325(7):669-685. PubMed ID: 33591350
[TBL] [Abstract][Full Text] [Related]
20. Current Targeted Therapy for Metastatic Colorectal Cancer.
Ohishi T; Kaneko MK; Yoshida Y; Takashima A; Kato Y; Kawada M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
